A Simplification Trial Switching From Nucleoside Reverse Transcriptase Inhibitors to Once-Daily Fixed-Dose Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1-Infected Patients With Virological Suppression Academic Article 2009 uri icon

authors

  • Martínez E
  • GUTIERREZ RODERO, FELIX
  • et al
  • Arranz JA
  • Podzamczer D
  • Loncá M
  • Sanz J
  • Barragán P
  • Ribera E
  • Knobel H
  • Roca V

publication date

  • 2009